Skip to content

Clinical trials

Phase 3 Autism Spectrum Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Phase: Phase 3 Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20102
20112
20132
20151
20172
20183
20191
20201
20212
20221
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated5
Not yet recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital5
AbbVie2
Bristol-Myers Squibb2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Seaside Therapeutics, Inc.2
Emory University1
Hoffmann-La Roche1
Holland Bloorview Kids Rehabilitation Hospital1
Indiana University1
Institut de Recherches Internationales Servier1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder23
Autistic Disorder9
Child Development Disorders, Pervasive3
Asperger Syndrome2
Parasomnias2
Schizophrenia2
Sleep Wake Disorders2
Angelman Syndrome1
Attention Deficit Disorder with Hyperactivity1
Bipolar Disorder1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.